MARIA CAPRIOTTI: Open Payments
NPI 1710226048 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 64 payments from 11 companies in 2025. Trend: 2023 $751 · 2024 $794 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $272 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $246 |
| Supernus Pharmaceuticals, Inc. | 20 | $194 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
| ABBVIE INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Bausch Health US, LLC | 1 | $22 |
| Tris Pharma Inc | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
Products named: Auvelity, CAPLYTA, Qelbree, Jornay PM, VRAYLAR, TRINTELLIX, REXULTI, INGREZZA.
Industry payments across PA — which companies pay providers there.
